The 20 Best Necrosis Doctors near Baltimore,, MD

David J. Hackam, M.D., Ph.D., is the Garrett Family Professor of Pediatric Surgery at The Johns Hopkins University, and Pediatric Surgeon-in-Chief and co-Director of the Johns Hopkins Children’s Center. Dr. Hackam’s clinical practice focuses on complex neonatal surgery. As pediatric surgeon in chief and co-director of the Childrens Center, Dr. Hackam oversees all perioperative clinical operations that involve children, with a strong emphasis on quality and safety, programmatic growth, and system alignment. Dr. Hackam's research is focused on unraveling the mechanisms of necrotizing enterocolitis, which is the leading cause of death in premature infants from gastrointestinal disease. His work has identified a series of novel pathways that, in response to the abnormal microflora that characterizes the premature intestine, leads to intestinal mucosal barrier breakdown, bacterial translocation, mesenteric vasoconstriction, and NEC. In seeking to translate these findings to clinical studies, we have developed a family of molecules that can prevent NEC development, and which have in part been licensed for clinical development. In additional work, Hackam has developed a prototype artificial intestine, derived from patient-specific intestine stem cells, which we have implanted into pre-clinical models, for the treatment of short bowel syndrome, a devastating complication of NEC. Finally, using single-cell RNA-seq and cell tracking technology, Hackam has worked towards understanding and treating NEC-associated brain injury, a major complication of NEC, and has engineered nanoparticle-packaged molecules that can cross the blood-brain barrier, and reverse the processes that lead to this disease. These studies are funded by three ro1s, a T32, a MIRA (a maximizing investigators’ research award) and 3 industry grants from companies with an interest in NEC treatment and prevention. Dr. Hackam seeks to work with industry partners, as well as nurses, doctors, and families of patients around the country, in order to develop novel regimens to safely and effectively deliver appropriate nutrition to the most vulnerable infants, who are at risk for the development of intestinal disease. Dr. Hackam is rated as an Elite provider by MediFind in the treatment of Necrosis. His top areas of expertise are Necrotizing Enterocolitis, Necrosis, Short Bowel Syndrome, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Dr. Thomas Stephen Metkus is an assistant professor of cardiology at the Johns Hopkins University School of Medicine. His research focuses on using cardiac physiology for risk stratification and therapeutics in non-cardiac critical illness such as sepsis and the acute respiratory distress syndrome (ARDS), and optimizing the management of non-cardiac organ failure in primary cardiac diseases such as heart failure and acute coronary syndromes. Dr. Metkus received his undergraduate degree from Boston University College of Engineering. He earned a medical degree from the University of Pennsylvania School of Medicine and completed a residency at Brigham and Women’s Hospital. After completing residency, Dr. Metkus was a clinical fellow at both Harvard Medical School and Johns Hopkins Hospital. Prior to joining the faculty at the Johns Hopkins Medical School he was an instructor of medicine at the Harvard Medical School. His educational focus includes teaching clinical cardiology and critical care, echocardiography, and electrocardiography to students, residents, and fellows at the Johns Hopkins Hospital. Videos Dr. Thomas Metkus. Dr. Metkus is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, and Inappropriate Sinus Tachycardia (IST).

Susie Hong is a Cardiologist in Baltimore,, Maryland. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Mitral Valve Regurgitation, Familial Ventricular Tachycardia, Necrosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Robert Hood is a Cardiologist in Baltimore,, Maryland. Dr. Hood is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Familial Ventricular Tachycardia, Necrosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Robert Benitez is a Cardiologist in Baltimore, Maryland. Dr. Benitez is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Cardiogenic Shock, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Zacharias V Mavrophilipos is a General Surgeon in Baltimore, Maryland. Dr. V Mavrophilipos is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Peptic Ulcer, Necrosis, Stasis Dermatitis and Ulcers, Venous Insufficiency, and Hernia Surgery.

Dimitrios Mavrophilipos is a General Surgeon in Baltimore, Maryland. Dr. Mavrophilipos is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Peptic Ulcer, Necrosis, Stasis Dermatitis and Ulcers, and Cellulitis.

James Black is a Vascular Surgeon in Baltimore, Maryland. Dr. Black is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Aortic Dissection, Carotid Artery Surgery, and Hernia Surgery.

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Abularrage specializes in vascular and endovascular surgery, with a specific interest in minimally invasive techniques for lower extremity peripheral arterial disease and aneurysm repair. His clinical interests include limb preservation, Diabetic peripheral arterial disease and limb salvage, aortic aneurysms, endovascular aneurysm repair, visceral stents and bypass, and carotid stents and carotid endarterectomy. Dr. Abularrage is an active researcher within the department and has published widely on outcomes research using large, national databases. Recently, Dr. Abularrage and his team have published their outcomes of patients treated in the Multidisciplinary Diabetic Foot & Wound Clinic, showing significantly lower amputation rates compared to national benchmarks. Dr. Abularrage is a distinguished fellow to the Society of the American Board of Surgery, and recipient of the Zehner Award and the R. Clement Darling, Jr. Award. He is nationally renowned for his work in Diabetic peripheral arterial disease and limb preservation. Dr. Abularrage is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Peripheral Artery Disease, Carotid Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement.

Dr. Samir Gautam, is an Assistant Professional of Medicine at Johns Hopkins School of Medicine with expertise in Nephrology and Critical Care Medicine. He staffs patients in Johns Hopkins Hospital, chronic dialysis clinics, Bayview Medical Center and clinic and also has a specialty clinic Post AKI clinic at Johns Hopkins Outpatient Center. Dr. Gautam is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis.

Dr. Lum is a clinically busy vascular surgeon specializing in the open and endovascular treatment of peripheral arterial disease, cartoid artery disease, dialysis access, mesenteric occlusive disease, arterial aneurysms and venous disease. In addition, he has a strong clinical & research interest in thoracic outlet syndrome. Dr Lum also has a Masters in Public Health from the Johns Hopkins School of Public Health. Dr. Lum is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Thoracic Outlet Syndrome, Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Carotid Artery Surgery, and Osteotomy.

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Bruce Perler completed his internship and residency in general surgery, and a clinical and research fellowship in vascular surgery, at the Massachusetts General Hospital in Boston. Dr. Perler had edited several textbooks including Vascular Intervention: A Clinical Approach, Advances in Vascular Surgery, and Rutherfords Vascular Surgery. He is currently the Co-Editor of Rutherford's Textbook of Vascular Surgery and Endovascular Therapy, 9th edition. He has authored nearly 200 peer-reviewed medical journal articles and textbook chapters on the diagnosis and treatment of the entire spectrum of circulatory diseases. He serves on the Editorial Boards of several vascular surgical journals, and has most recently served as the Senior Editor of The Journal of Vascular Surgery, the Journal of Vascular Surgery: Venous and Lymphatic Disorders, and the Journal of Vascular Surgery Cases. He has delivered more than 200 lectures at national and international symposia and postgraduate courses. He serves on the Board of Directors of the Society for Vascular Surgery, and is past president of the Eastern Vascular Society the Southern Association for Vascular Surgery, and the Chesapeake Vascular Society. He also is the immediate past president of the Society for Vascular Surgery, the largest vascular surgical organization in the world with more than 5,400 members. In December 2015, he was named Associate Executive Director for Vascular Surgery of the American Board of Surgery (ABS). In this position, Dr. Perler oversees all ABS activities associated with vascular surgery assessment and board certification. He will continue to work at Johns Hopkins, both practicing vascular and endovascular surgery and in his departmental administrative position, while fulfilling this role at the ABS. “Dr. Perler’s vast experience in vascular surgery education will be a tremendous asset as we seek to continuously improve our certification and MOC processes for vascular surgeons,” said Dr. Frank R. Lewis, executive director of the American Board of Surgery at the time of the announcement. “We look forward to the contributions Dr. Perler will bring to the ABS.”. Dr. Perler is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Carotid Artery Disease, Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement.

Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies. Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia. Dr. Lima is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Atherosclerosis, Heart Attack, Apoplexy, Arterial Embolism, and Bone Marrow Aspiration.

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as an Advanced provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Heart Attack, and Apoplexy.

Maurizio Colognesi is a Cardiologist in Baltimore, Maryland. Dr. Colognesi is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Pulmonary Edema, Heart Failure, Heart Attack, and Apoplexy.

Dr. Mohamad Hanouneh is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Hanouneh grew up in Syria and completed his medical school in Tishreen University in Latakia, Syria. He completed Internal Medicine Residency training at Cleveland Clinic, and Nephrology Fellowship at Johns Hopkins. Dr. Hanouneh currently serves as a part-time faculty in the Division of Nephrology at Johns Hopkins. He also works in the Nephrology Center of Maryland covering Good Samaritan and Upper Chesapeake Hospitals. Dr. Hanouneh has a passion in medical education. He runs the nephrology board review course and participates in Genes to Society Course of Renal Physiology, which is given to the medical students at Johns Hopkins University School of Medicine. His area of interests are electrolytes disorders, diabetic kidney disease and nephrolithiasis. Dr. Hanouneh is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Low Potassium Level, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and High Potassium Level.

Dr. Jeffrey C. Trost is an associate professor of medicine at the Johns Hopkins School of Medicine as well as director of the Cardiac Catheterization Laboratory at Johns Hopkins Bayview Medical Center. His research there focuses on cardiac disease and cardiovascular medicine. He is also currently deputy director of clinical activities at Johns Hopkins Bayview Medical Center. Dr. Trost earned his undergraduate degree at Princeton University and medical degree at the University of Pennsylvania School of Medicine. He completed a residency at the University of Texas Southwestern School of Medicine where he was chief resident from 1999-2000. He was an assistant professor of internal medicine at the University of Texas Southwestern School of Medicine and an interventional cardiovascular fellow at Brown University before joining the Johns Hopkins faculty in 2005. Dr. Trost was most recently recognized with the 2016 Hopkins Medicine Clinical Recognition Award for Quality and Safety and the 2016 Hopkins Cardiology Fellows’ Teaching Award. Dr. Trost is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.